Biopharmas in Asia-Pacific raising money in public or private financings, including: Biocure Pharm, Bristol Myers Squibb, Harbour Biomed, Life Sciences Partners, Otsuka, Quest Pharmatech, Tiziana Life Sciences.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Cytodyn, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Moderna, Regeneron, Sanofi, Santen, Takeda, Tracon.

Med-tech firms raising money in public or private financings, including: Pristine Surgical.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hologic, Neural Fiber Optic Systems, Medx Health.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied Extracts, Arima Genomics, Asuragen, Aytu Bioscience, Becton, Dickinson and Co., Biogx, Blue Earth Diagnostics, Bracco Imaging, Caredx, Cefaly, Co-Diagnostics, Datos, Geacom, Haselmeier, Healthcall, Heiq Materials, IDbyDNA, Illumina, Impulse Dynamics, Invo Bioscience, Nobio, Pharmajet, Qiagen, Roche, Supergum, Tandem Diabetes Care, Twist, West China Hospital, XCR Diagnostics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Artio Medical, Dermtech, Horiba Medical, Oncosec.

New hires and promotions in the med-tech industry, including: Centogene, Clarify Medical, First Sensor, Thrive Earlier Detection.

Quarterly snapshots from biopharma companies with marketed products, including: Catalyst Pharmaceuticals.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: DBV, Mallinckrodt.